Subsequently, we associated TERTp mutations, IDH mutations, and MGMT methylation with clinicopathological features from glioma patients and pooled analysis was performed, including sex, age, tumor location, histology, pathologic stage, and Ki-67 protein expression. This evidence concerns the gene MGMT and neoplasm.